AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17070365
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg tadalafil
Trial: 17125930
Drug: l-Arg (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Arg (400 mg/kg/day)
Trial: 17125930
Drug: l-Arg (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Arg (200 mg/kg/day)
Trial: 17125930
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no l-Arg supplementation)
Trial: 11444449
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 0.5 mL
Trial: 11435054
Drug: Gallamine 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallamine 0.04 mg/kg
Trial: 7878625
Drug: Hirulog 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirulog 1.0 mg/kg subcutaneously
Trial: 7878625
Drug: Hirulog 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirulog 0.6 mg/kg as a 15 min intravenous infusion
Trial: 3067338
Drug: Olsalazine, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine, 2 g/day
Trial: 29786964
Drug: Laquinimod 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laquinimod 0.6 mg/day
Trial: 17043157
Drug: Spironolactone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50 mg per day)
Trial: 10397122
Drug: Negative contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative contrast agent (30 patients)
Trial: 28580810
Drug: Youth Empowerment
RxNorm normalized name: influenza A virus A/South Australia/34/2019 (H3N2) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Youth Empowerment Solutions (YES) program
Trial: 30352746
Drug: Homeopathic vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic vaccine
Trial: 20453154
Drug: Aerobic treadmill
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic treadmill exercise (T-EX) therapy
Trial: 1967425
Drug: Matching placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo tablets
Trial: 6751339
Drug: Bromocriptine (30-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (30-50 mg daily)
Trial: 6751339
Drug: Amitriptyline (120-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (120-200 mg daily)
Trial: 15220226
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day Alendronate (ALN) for 2 years, followed by 10 mg/day for the remainder of the trial
Trial: 17000586
Drug: Low-dose hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose hormone therapy (1 mg estradiol plus 0.5 mg norethisterone)
Trial: 30938806
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control (NC) diet with 1.3 g nPP/kg starter diet or 1.1 g nPP/kg grower diet
Trial: 30938806
Drug: NC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NC treatment
Trial: 7632811
Drug: rHu-EPO at
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rHu-EPO at an initial dosage of 150 units/kg body weight three times a week, increased to 300 units/kg from the sixth week to the end of the 24-week study
Trial: 7632811
Drug: rHu-EPO-untreated patients
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rHu-EPO-untreated patients undergoing alpha-IFN + VMCP combined therapy
Trial: 26529118
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg
Trial: 11239185
Drug: Neuroprotective drugs
RxNorm normalized name: NEUROPROTECTIN D1
DrugBank: AP-001 (DB18511)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroprotective drugs
Trial: 9239588
Drug: Convection cooling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Convection cooling (CC)
Trial: 2442957
Drug: Free diet
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free diet with tyrosine (160 mg/kg/24 h)
Trial: 30788529
Drug: Baclofen 30
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen 30 mg
Trial: 30788529
Drug: Baclofen 75
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen 75 mg
Trial: 20146136
Drug: Dual-task training
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-task training (experimental treatment)
Trial: 12570122
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin (400 mg o.d.)
Trial: 12570122
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral therapy (amoxicillin 1 g t.i.d. or clarithromycin 500 mg b.i.d. alone or in combination)
Trial: 8946270
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg twice a day for 12 months
Trial: 6126961
Drug: propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol (40 mg t.i.d.)
Trial: 26881251
Drug: Ranirestat 20
RxNorm normalized name: Ranirestat
DrugBank: Ranirestat (DB05327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranirestat 20 mg once daily
Trial: 24708851
Drug: Complete Decongestive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete Decongestive Therapy without manual lymphatic drainage
Trial: 24708851
Drug: Complete Decongestive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete Decongestive Therapy including manual drainage
Trial: 22769857
Drug: Ultracet (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultracet (37.5 mg tramadol/325 mg APAP)
Trial: 22769857
Drug: Depain‐X (65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depain‐X (65 mg propoxyphene/650 mg APAP)
Trial: 20144496
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate (1 mL) plus Ringer lactate during arthroscopy
Trial: 7675981
Drug: Inositol as
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inositol as sole therapy for depression
Trial: 7148050
Drug: Lidocaine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1.0 mg/kg body weight)
Trial: 23686414
Drug: Immediate combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate combination therapy
Trial: 16214598
Drug: Pioglitazone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (15 mg to 45 mg)
Trial: 20158090
Drug: Glimepiride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (1 to 4 mg)
Trial: 18258791
Drug: Topical esophageal
RxNorm normalized name: Cellspan Esophageal Implant
DrugBank: Cellspan Esophageal Implant (DB18688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical esophageal lidocaine (15 ml)
Trial: 18258791
Drug: Baclofen (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (40 mg orally)
Trial: 16636123
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg potassium perchlorate daily
Trial: 16636123
Drug: 3.0 mg
RxNorm normalized name: TOBRAMYCIN 3.0 mg in 1 mL OPHTHALMIC SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 mg potassium perchlorate daily
Trial: 2867560
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg naproxen sodium initially and then 275 mg naproxen sodium 4-times daily
Trial: 2867560
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg dextropropoxyphene napsylate initially and then 100 mg dextropropoxyphene napsylate 4-times daily
Trial: 24553997
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid (2,000 mg of eicosapentaenoic acid and docosahexaenoic acid)
Trial: 24553997
Drug: Gamma-linoleic acid
RxNorm normalized name: gamma linoleic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-linoleic acid (borage oil containing 400 mg γ-linoleic acid)
Trial: 20533764
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate (SR) 2 g/day
Trial: 8372340
Drug: Simvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (10 mg/d)
Trial: 20199786
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/d)
Trial: 12952834
Drug: Enzyme replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme replacement therapy (ERT) with 1.0 mg/kg body weight of recombinant alpha‐Gal A (agalsidase beta, Fabrazyme) for 12 months
Trial: 18768350
Drug: Losartan 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 150 mg
Trial: 4089261
Drug: 125I permanent
RxNorm normalized name: fibrinogen (125I)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125I permanent implant
Trial: 15365074
Drug: Gemcitabine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine monotherapy (GEM)
Trial: 22446296
Drug: APG101 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APG101 (20 mg/kg) administered as infusion over 1 hour to healthy volunteers
Trial: 10393400
Drug: n-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: n-acetylcysteine (NAC) in combination with streptokinase
Trial: 3593901
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg
Trial: 6599496
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (AII) infusion at 7.5 ng/kg/min
Trial: 23134084
Drug: Ursolic acid
RxNorm normalized name: Ursolic Acid
DrugBank: Ursolic acid (DB15588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursolic acid liposomes (UAL) at doses of 11, 22, 37, 56, 74, 98, and 130 mg/m(2) administered as a 4-h intravenous infusion
Trial: 18311687
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg amitriptyline
Trial: 9126089
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg paroxetine
Trial: 16573705
Drug: Budesonide 200
RxNorm normalized name: budesonide 200 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 200 microg once daily
Trial: 12699032
Drug: Sudden within-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sudden within-treatment gain
Trial: 10960384
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 0.2 mg (Group 1)
Trial: 10960384
Drug: Intrathecal nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal nalbuphine 0.2 mg (Group 2)
Trial: 10960384
Drug: Intrathecal nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal nalbuphine 0.8 mg (Group 3)
Trial: 10960384
Drug: Intrathecal nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal nalbuphine 1.6 mg (Group 4)
Trial: 24115083
Drug: Intravesical 100
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical 100 U onabotulinumtoxinA injection
Trial: 23911756
Drug: β‐blockers (BB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐blockers (BB)
Trial: 30919005
Drug: Haloperidol (0.057
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.057 mg/kg)
Trial: 12091491
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 1,000 mg/d
Trial: 24665980
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 750 mg/d
Trial: 2403006
Drug: Somatropin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin 0.1 mg/kg (0.27 IU/kg) three times weekly (second year)
Trial: 2403006
Drug: Somatropin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin 0.1 mg/kg (0.27 IU/kg) once-daily (second year)
Trial: 2403006
Drug: Original treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original treatment regimen (first year) continued (second year)
Trial: 25052847
Drug: Amitriptyline (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (25 mg)
Trial: 9531895
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray applied to the cervix and cervical canal
Trial: 12269652
Drug: Mizolastine 10
RxNorm normalized name: mizolastine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine 10 mg
Trial: 2879489
Drug: Terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 120 mg
Trial: 2084590
Drug: Atracurium 5
RxNorm normalized name: cisatracurium 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 5 mg i.v.
Trial: 25774017
Drug: Normal medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal medication dispensing (Control Group)
Trial: 22251226
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly (QW)
Trial: 9190973
Drug: Combined hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormone replacement therapy (HRT)
Trial: 10383519
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg lansoprazole b.d. (LAC15 group)
Trial: 10383519
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg lansoprazole b.d. (LAC30 group)
Trial: 1687852
Drug: Theophylline (625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (625 mg orally) followed by adenosine infusion (40 micrograms kg‐1 min‐1 for 5 min, 60 micrograms kg‐1 min‐1 for 5 min, and 80 micrograms kg‐1 min‐1 for 30 min)
Trial: 1687852
Drug: Theophylline (625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (625 mg orally)
Trial: 1687852
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion only
Trial: 6366805
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg furosemide
Trial: 3885701
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg chlorthalidone
Trial: 17201610
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both treatments
Trial: 27619104
Drug: Yoga practice
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga practice (1 hour daily for 12 weeks)
Trial: 22499962
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin based on the weight-based dosing nomogram
Trial: 12527527
Drug: Bupivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (20 ml)
Trial: 1871399
Drug: Program of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program of prevention of ill-treatment of very young children
Trial: 22176795
Drug: Ulipristal acetate
RxNorm normalized name: Ulipristal Acetate
DrugBank: Ulipristal (DB08867)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ulipristal acetate (UPA) delivered via contraceptive vaginal ring, 600-800 mcg
Trial: 14622078
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Nefazodone + CBASP)
Trial: 10455342
Drug: G-CSF treatment
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF treatment starting at day 6
Trial: 8569137
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of fentanyl and midazolam
Trial: 8569137
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose application of fentanyl and midazolam
Trial: 1549538
Drug: Ofloxacin 300
RxNorm normalized name: ofloxacin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 300 mg
Trial: 23513199
Drug: 10 to
RxNorm normalized name: RE-10 Topical Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 to 16 mm-long hydroxyapatite-coated implants after lateral sinus lifting with 50% organic bovine (Bio-Oss) and 50% autogenous bone (20 patients)
Trial: 23513199
Drug: 8 mm
RxNorm normalized name: potassium 8 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mm implants after crestal sinus lifting with autogenous bone (20 patients)
Trial: 23513199
Drug: Long implants
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implants
Trial: 7917814
Drug: Other preparations
RxNorm normalized name: other preparations, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other preparations of lignocaine gel (exact details not specified)
Trial: 23446897
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake of 480 mg/d
Trial: 22326568
Drug: Open oral
RxNorm normalized name: amopen Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open oral challenge test with 200 mL of low-lactose cow's milk
Trial: 21212155
Drug: Sorafenib (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (800 mg/day) + Gemcitabine (1200 mg/m² on days 1 and 8, every 21 days for a maximum of six cycles)
Trial: 16932240
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch (300 microg/day)
Trial: 3282032
Drug: Long-term maintenance
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term maintenance chemotherapy
Trial: 22447850
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both medications
Trial: 20539246
Drug: Desvenlafaxine (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine (100-200 mg/d)
Trial: 8610868
Drug: Hyaluronidase (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronidase (100 IU = 2 mL) with bupivacaine 0.5% (5.5 mL) and lidocaine 2% (5.5 mL)
Trial: 8610868
Drug: Plain bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain bupivacaine 0.5% (5.5 mL) and lidocaine 2% (5.5 mL) without hyaluronidase
Trial: 3101549
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 0.2 mg/kg
Trial: 3101549
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 0.4 mg/kg
Trial: 3101549
Drug: Ketamine 1.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1.1 mg/kg
Trial: 27916213
Drug: Esomeprazole (40mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (40mg once daily)
Trial: 27916213
Drug: Esomeprazole (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (dose increased for nonresponders)
Trial: 20958958
Drug: Assertive community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assertive community treatment for the elderly
Trial: 10831008
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aqueous nasal spray
Trial: 1732426
Drug: Carboplatin 560
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 560 mg/m2 at 4-week intervals
Trial: 1732426
Drug: Iproplatin 270
RxNorm normalized name: Aroplatin
DrugBank: Aroplatin (DB17319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iproplatin 270 mg/m2 at 3-week intervals
Trial: 3891946
Drug: Routine phototherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine phototherapy (after serum bilirubin concentration reached 5 mg/dl)
Trial: 30918997
Drug: Arthroscopic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthroscopic treatment
Trial: 16278618
Drug: E(2) 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E(2) 0.5 mg
Trial: 15790044
Drug: Albendazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (800 mg/d for 28 days)
Trial: 12358344
Drug: Tobramycin nebuliser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin nebuliser solution (TNS)